BlackRock Investment Management’s Coherus Oncology CHRS Stock Holding History

BlackRock Investment Management’s Portfolio CHRS Stock Details CHRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$3.25M	Sell	115,414 -646	-0.6%	-$18.1K	﹤0.01%	1870
2016 Q3	$3.11M	Buy	116,060 +1,978	+2%	+$54K	﹤0.01%	1822
2016 Q2	$1.93M	Buy	114,082 +30,179	+36%	+$567K	﹤0.01%	2131
2016 Q1	$1.78M	Buy	83,903 +1,702	+2%	+$27.9K	﹤0.01%	2081
2015 Q4	$1.89M	Buy	82,201 +22	+0%	+$566	﹤0.01%	2124
2015 Q3	$1.65M	Sell	82,179 -1,067	-1%	-$32.5K	﹤0.01%	2217
2015 Q2	$2.41M	Buy	+83,246	New	+$2.1M	﹤0.01%	2081

Other funds holding CHRS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Investment Management's CHRS Position: Q4 2016 in Review

BlackRock Investment Management reduced its Coherus Oncology (CHRS) stake by 0.56% in Q4 2016, selling an estimated $18.1K and leaving 115,414 shares worth $3.25M. The position accounts for ﹤0.01% of the portfolio, ranked #1870.

BlackRock Investment Management first reported a position in CHRS in Q2 2015 and has held it in 7 quarters since. 122 funds tracked by Wall St. Rank hold CHRS as of Q4 2016.

BlackRock Investment Management held 115,414 shares of Coherus Oncology worth $3.25M as of Q4 2016.
BlackRock Investment Management sold 646 Coherus Oncology shares in Q4 2016, an estimated $18.1K.
Coherus Oncology made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #1870 holding.
BlackRock Investment Management first reported a position in Coherus Oncology in Q2 2015 and has held it in 7 quarters since.
122 funds tracked by Wall St. Rank held Coherus Oncology as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.